bpc-157 regulatory fda warning Before the FDA: Briefing Document Focuses on… is the fda banning bpc
Description
Designed for reproducibility in experimental settings

J., Donaldson, W
[DOI] [Google Scholar] Eigen M

When BPC-157 is used alone, many patients feel better, return to activity, and then discover the tissue is not yet resilient

Medical directors need to review protocols, especially if a patient doesn't respond after 4-6 weeks, side effects appear, or new regulations come up
